央视网新闻: Yesterday (8th) afternoon at the State Council Joint Prevention and Control Mechanism press conference, it was raised in response to foreign media reporters that now the global epidemic situation is rising, can China’s medical supplies supply capacity keep up The rising demand for foreign orders? Huang Libin, spokesperson of the Ministry of Industry and Information Technology and director of the Operation Monitoring and Coordination Bureau, said that Chinese companies are doing everything possible to provide support for the global fight against the epidemic, but there are still many constraints such as insufficient supply of core parts and different quality standards between China and foreign countries.
The spokesperson of the Ministry of Industry and Information Technology, the Director of the Operation Monitoring Coordination Bureau Huang Libin: While safeguarding the prevention and control of the domestic epidemic, our company is working overtime and is doing everything possible to provide support for the global fight against the epidemic. The spread of the epidemic situation can expand production. However, it should also be noted that in the face of huge international demand, our capabilities are also limited, and there are also many factors that restrict the development of my country's medical assets and the improvement of supply capabilities. For example, the production of ventilators, which the global media pay attention to, is restricted by the shortage of global core parts and components. China’s production capacity is less than one-fifth of the world’s. Even when the supply of key parts is guaranteed, it wants to fully meet the global epidemic prevention. The need for control is also not realistic.
For another example, the global guarantee of protective clothing is also restricted by differences in quality standards and usage habits between China and foreign countries. The current average daily output of protective clothing in my country has exceeded 1.5 million sets. In theory, the problem of meeting the needs of the international market is not too big. However, these protective clothing are produced in accordance with different quality standard systems such as China, the United States, the European Union, and Japan, and do not completely match the relevant requirements of the importing countries and regions.
Recently, the Ministry of Commerce, the General Administration of Customs, the State Administration for Market Regulation, and the State Food and Drug Administration issued regulations that require the export of five types of products including testing reagents. Domestic production must obtain the qualifications of China’s drug regulatory authorities. Meet the quality standard requirements of importing countries and regions.
